TREATING

Central Sleep Apnea

MEDIA KIT

Media Contact
Collin Anderson
Vice President of Marketing
+1-952-540-4474
canderson@respicardia.com

About the remedē® System

The remedē System is a breakthrough implantable system that safely and effectively treats moderate to severe central sleep apnea (CSA) in adult patients. CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact quality of life and heart health.1

In a clinical study, the remedē System has been shown to improve sleep, oxygen levels and enhance overall quality of life:

  • 87% of patients had a reduction in Apnea-Hypopnea Index, an indication of CSA severity2,3
  • 79% of patients had an improvement in quality of life2,4
  • 91% of patients were free from serious adverse events related to the implant procedure, the device, or delivered therapy at 12 months2
  1. Costanzo MR, Khayat R, Ponikowski P, et al. State-of-the-art review: Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol 2015;65:72-84.
  2. Costanzo M, et al. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. The Lancet. 2016; 388: 974–82.
  3. 48% of the control group had a positive change in AHI.
  4. 13% of the control group had an improvement in quality of life.

The remedē® System Clinical Trial News Releases

Am I a candidate
for remedē®?

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

CLOSE

For Patients

IMPORTANT SAFETY INFORMATION

The remedē® System is indicated for moderate to severe Central Sleep Apnea in adult patients.

Your doctor will need to evaluate your condition to determine if the remedē system is right for you. You will not be able to have an MRI or diathermy (special heat therapies) if you have the remedē system implanted. The remedē system may be used if you have another stimulation device such as a heart pacemaker or defibrillator; special testing will be needed to ensure the devices are not interacting.

As with any surgically implanted device, there are risks related to the surgical procedure itself which may include, but are not limited to, pain, swelling, and infection.

Once the therapy is turned on, some patients may experience discomfort from stimulation and/or from the presence of the device. The majority of these events are resolved either on their own or by adjusting the therapy settings. The remedē system may not work for everyone. There are additional risks associated with removing your system. If you and your doctor decide to remove the system, another surgery will be required.

Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the remedē system. Rx only. For further information, please call +1-952-540-4470 or email info@respicardia.com.